RE: Sold Out19 Sep 2020 11:55
Morning Sandhopper,
I quite agree, and I remembered after posting my comments that some shareholders bought in when the SP was 20-30p, and despite averaging down, the SP would have to increase drastically before they break even. If Chester's comments are correct (and I have no reason to think otherwise), you may well break even next year, for others it could be much longer.
It's difficult to compare TRX SP with other biotech companies, because they appear to cornering a new market. Whilst it's probably not helpful to do so either (I was just being nosy), I saw nothing to make me reconsider my position.
I genuinely believe we have reason to expect more good news than bad, but who knows? There will be bumps along the way, it's just a question of whether we can weather the storm, because the demand is definitely there.